Versant Capital Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Versant Capital Management’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-63	Closed	–	–	1773
2018 Q3	$0	Hold	63	–	–	﹤0.01%	1739
2018 Q2	$0	Hold	63	–	–	﹤0.01%	1727
2018 Q1	$0	Hold	63	–	–	﹤0.01%	1756
2017 Q4	$0	Hold	63	–	–	﹤0.01%	1720
2017 Q3	$0	Hold	63	–	–	﹤0.01%	1650
2017 Q2	$0	Hold	63	–	–	﹤0.01%	1620
2017 Q1	$0	Hold	63	–	–	﹤0.01%	1611
2016 Q4	$0	Hold	63	–	–	﹤0.01%	1613
2016 Q3	$0	Hold	63	–	–	﹤0.01%	1568
2016 Q2	$0	Hold	63	–	–	﹤0.01%	1518
2016 Q1	$0	Hold	63	–	–	﹤0.01%	1539
2015 Q4	$0	Buy	+63	New	+$64	﹤0.01%	1482

Versant Capital Management's BTX.WS Position: Q4 2018 in Review

Versant Capital Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2018, closing a stake of 63 shares.

Versant Capital Management first reported a position in BTX.WS in Q4 2015 and held it in 12 quarters. The position peaked at $0 in Q3 2018. 0 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2018.

Versant Capital Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2018 after selling out during the quarter.
Versant Capital Management sold 63 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2018.
Versant Capital Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2015 and held it in 12 quarters.
Versant Capital Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q3 2018.
0 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2018.

Based on Versant Capital Management's 13F filing for Q4 2018, filed 29 Jan 2019.